Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01359527 · ClinicalTrials.gov registry record

Dual Energy X-ray Absorptiometry (DXA) Comparison Hip Resurfacing Versus Total Hip Arthroplasty (THA)

A clinical trial of Osteoarthritis, Hip, sponsored by Spokane Joint Replacement Center.

Completed
Registry status
31
Enrollment target
1
Study location

NCT01359527: Completed study of Osteoarthritis, Hip, sponsored by Spokane Joint Replacement Center.

NCT01359527 is a study of Osteoarthritis, Hip that has completed, run by Spokane Joint Replacement Center. The registered enrollment target is 31 participants, below the 1,272-participant average among 20 other Osteoarthritis, Hip trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01359527, a study of Osteoarthritis, Hip, has completed, sponsored by Spokane Joint Replacement Center.

COMPLETED
Registry status
31 participants
Enrollment target
1
Study location

Study Summary

This study compares the change (loss) of bone mineral density (BMD) that occurs in the proximal femur after hip resurfacing and total hip replacement.

Primary Outcome

To evaluate the bone loss in the proximal femur resulting from hip resurfacing surgery and to compare this to the bone loss in the proximal femur resulting from total hip arthroplasty.

Conditions Studied

Interventions

  • DEVICE Hip Resurfacing
  • DEVICE Total Hip Arthroplasty

Study Locations (1)

Washington

  • Spokane Joint Replacement Center - Spokane

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2008-12
Est. Completion 2018-11
Spokane Joint Replacement Center

5 total trials

What the finished NCT01359527 record still lists

NCT01359527 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 1,272-participant average among 20 other Osteoarthritis, Hip trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Osteoarthritis, Hip appearing as the primary indexed condition, and to 2 interventions - of which Hip Resurfacing is the first listed.

NCT01359527 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT01359527 about?

NCT01359527 is a clinical study titled "Dual Energy X-ray Absorptiometry (DXA) Comparison Hip Resurfacing Versus Total Hip Arthroplasty (THA)". This study compares the change (loss) of bone mineral density (BMD) that occurs in the proximal femur after hip resurfacing and total hip replacement.

What is the current status of trial NCT01359527?

This trial is currently completed. The enrollment target is 31 participants. The study started on 2008-12. Estimated completion is 2018-11.

What conditions does trial NCT01359527 study?

This clinical trial studies the following conditions: Osteoarthritis, Hip.

What interventions are being tested in trial NCT01359527?

The interventions under investigation include: Hip Resurfacing (DEVICE), Total Hip Arthroplasty (DEVICE).

Who is sponsoring clinical trial NCT01359527?

This trial is sponsored by Spokane Joint Replacement Center, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01359527 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoarthritis, Hip

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01359527's enrollment target sits among peer trials

31 19th of 20 higher than 2 of 20 other Osteoarthritis, Hip trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Osteoarthritis, Hip trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02932618 · 31 participants · Phase 3

    A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)

  • NCT03482297 · 31 participants · Phase 1

    Automated Abdominal Binder for Orthostatic Hypotension

  • NCT04016389 · 31 participants · NA

    FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery

  • NCT04211675 · 31 participants · Phase 1

    NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01359527, the US trial registry maintained by the National Library of Medicine. NCT01359527 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.